We are live on
!
Find out more
PA
Pinnacle Associates Portfolio holdings
AUM
$9.16B
1-Year Est. Return
63.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.57%
1 Year Est. Return
+63.5%
3 Year Est. Return
+138.65%
5 Year Est. Return
+164.85%
10 Year Est. Return
+932.39%
AUM
$4.45B
AUM Growth
–
Cap. Flow
+$4.44B
Cap. Flow
% of AUM
99.87%
Top 10 Holdings %
Top 10 Hldgs %
20.21%
Holding
546
New
540
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$145M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$104M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$96.2M |
| 4 |
Las Vegas Sands
LVS
|
+$91.5M |
| 5 |
Cummins
CMI
|
+$88.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.82% |
| 2 | Communication Services | 12.17% |
| 3 | Technology | 11.91% |
| 4 | Healthcare | 11.65% |
| 5 | Energy | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Omega Healthcare
OHI
$14.7B
| $6.34M | 0.14% |
+204,346
| New | +$6.72M |
|
152
Goldman Sachs
GS
$303B
| $6.28M | 0.14% |
+41,508
| New | +$6.33M |
|
|
IO
153
DELISTED
ION Geophysical Corporation
IO
| $6.28M | 0.14% |
+69,496
| New | +$6.49M |
|
|
ECYT
154
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $6.15M | 0.14% |
+468,680
| New | +$6.32M |
|
155
PNC Financial Services
PNC
$101B
| $6.08M | 0.14% |
+83,437
| New | +$5.78M |
|
156
McDonald's
MCD
$195B
| $6M | 0.13% |
+60,588
| New | +$6.07M |
|
157
Teva Pharmaceuticals
TEVA
$41.2B
| $5.98M | 0.13% |
+152,532
| New | +$5.94M |
|
158
Sanofi
SNY
$104B
| $5.95M | 0.13% |
+115,482
| New | +$6.15M |
|
159
Mattel
MAT
$4.23B
| $5.94M | 0.13% |
+131,038
| New | +$5.87M |
|
160
Becton Dickinson
BDX
$48.2B
| $5.91M | 0.13% |
+61,281
| New | +$5.84M |
|
161
Baxter International
BAX
$14.2B
| $5.85M | 0.13% |
+155,555
| New | +$5.96M |
|
162
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.49B
| $5.82M | 0.13% |
+55,180
| New | +$6.02M |
|
163
Target
TGT
$68B
| $5.73M | 0.13% |
+83,220
| New | +$5.79M |
|
164
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
| $5.68M | 0.13% |
+77,330
| New | +$5.7M |
|
165
Waste Management
WM
$91B
| $5.57M | 0.13% |
+137,988
| New | +$5.57M |
|
166
3M
MMM
$94.3B
| $5.54M | 0.12% |
+60,646
| New | +$5.51M |
|
167
Novartis
NVS
$297B
| $5.52M | 0.12% |
+87,167
| New | +$5.67M |
|
168
Accenture
ACN
$108B
| $5.46M | 0.12% |
+75,826
| New | +$6.02M |
|
169
Ingredion
INGR
$6.58B
| $5.42M | 0.12% |
+82,635
| New | +$5.81M |
|
|
YHOO
170
DELISTED
Yahoo Inc
YHOO
| $5.4M | 0.12% |
+214,925
| New | +$5.45M |
|
171
Colgate-Palmolive
CL
$74.4B
| $5.38M | 0.12% |
+93,935
| New | +$5.58M |
|
172
Paychex
PAYX
$42.7B
| $5.33M | 0.12% |
+145,871
| New | +$5.37M |
|
173
CF Industries
CF
$17.3B
| $5.27M | 0.12% |
+153,610
| New | +$5.73M |
|
|
CBI
174
DELISTED
Chicago Bridge & Iron Nv
CBI
| $5.26M | 0.12% |
+88,191
| New | +$5.12M |
|
175
Vanguard Total Bond Market
BND
$161B
| $5.21M | 0.12% |
+64,470
| New | +$5.35M |
|
Similar funds
LCAM
SFM
HKAM
SUT
VAS
A
IAA
AI
Pinnacle Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Pinnacle Associates, which disclosed 546 positions worth $4.45B. Its ten largest holdings account for 20% of the portfolio.
Its largest position is Regeneron Pharmaceuticals: 623,202 shares worth $140M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, followed by Communication Services and Technology.
- Pinnacle Associates's largest Q2 2013 buy was Regeneron Pharmaceuticals: 623,202 shares worth $140M.
- Pinnacle Associates's ten largest holdings make up 20% of its $4.45B portfolio in Q2 2013.
- Pinnacle Associates disclosed 546 positions in Q2 2013, its first 13F filing on record.
Based on Pinnacle Associates's 13F filing for Q2 2013, filed 13 Aug 2013.